about-me variable
LYSARC & CALYM invites you to their event

RedTalks #7: From 2 Cancer Centers to Industry: Driving Progress in Blood Cancers

About this event

CALYM Institute launches its RedTalks, a Series of scientific Webinars

RedTalks #7: From 2 Cancer Centers to Industry: Driving Progress in Blood Cancers

We are very honored to present our next guest:

Dr. Anas Younes, Senior Vice President, and Global Head of Hematology R&D at AstraZeneca.

Publications : Astrazeneca, Nat Rev Dis Primers, Blood Rev

Dr. Anas Younes has spent more than 25 years caring for patients with lymphoma in addition to leading a laboratory focused on drug development for patients with lymphoid malignancies. His lab has focused on accelerating the translation of scientific discoveries into novel treatment strategies to improve the cure rate and survival of patients with Hodgkin lymphoma (HL) and non-Hodgkin lymphoma (NHL). After leading the approval of the first immune checkpoint inhibitor for lymphoma and leading numerous clinical trials, Dr. Anas Younes shares with us his background as a researcher and as a haematologist and explains the necessary steps to develop a new generation of medicines that will transform lives of people with blood cancers.

This RedTalk will be hosted by Pr Steven Le Gouill, hematologist at Nantes University Hospital and by Pr. Gilles Salles, Chief of the Lymphoma Service at the Memorial Sloan Kettering Cancer Center NY, NY, USA

👉 More informations about CALYM on lymphoma-research-experts.org/calym

Hosted by

  • Guest speaker
    SL G
    Steven Legouill Chef de service Service d'hématologie clinique @ CHU de Nantes

  • Guest speaker
    AY G
    Anas Younes

  • Guest speaker
    GS G
    Gilles Salles

  • Guest speaker
    AB G
    Amel Bkz

  • Guest speaker
    BN G
    Bertrand Nadel